Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study

The Lancet. Psychiatry
Elaine SetiawanJeffrey H Meyer

Abstract

People with major depressive disorder frequently exhibit increasing persistence of major depressive episodes. However, evidence for neuroprogression (ie, increasing brain pathology with longer duration of illness) is scarce. Microglial activation, which is an important component of neuroinflammation, is implicated in neuroprogression. We examined the relationship of translocator protein (TSPO) total distribution volume (VT), a marker of microglial activation, with duration of untreated major depressive disorder, and with total illness duration and antidepressant exposure. In this cross-sectional study, we recruited participants aged 18-75 years from the Toronto area and the Centre for Addiction and Mental Health (Toronto, ON, Canada). Participants either had major depressive episodes secondary to major depressive disorder or were healthy, as confirmed with a structured clinical interview and consultation with a study psychiatrist. To be enrolled, participants with major depressive episodes had to score a minimum of 17 on the 17-item Hamilton Depression Rating Scale, and had to be medication free or taking a stable dose of medication for at least 4 weeks before PET scanning. Eligible participants were non-smokers; had no history...Continue Reading

Citations

Jan 12, 2019·British Journal of Pharmacology·Francis J HermanGiulio M Pasinetti
Apr 26, 2019·Journal of Psychopharmacology·Pedro Antônio Schmidt do Prado-LimaJaderson Costa daCosta
May 30, 2019·Current Neurology and Neuroscience Reports·Christine GhaderyAntonio P Strafella
May 15, 2019·Current Opinion in Neurology·Sabine Hellwig, Katharina Domschke
Nov 5, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sophia AttwellsJeffrey H Meyer
May 30, 2019·Molecular Psychiatry·D S AlbrechtM L Loggia
May 21, 2020·Translational Psychiatry·Forugh S Dafsari, Frank Jessen
Jul 17, 2020·The International Journal of Neuropsychopharmacology·Wataru OmoriMinoru Takebayashi
Aug 26, 2020·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Jeong Hoon ParkUNKNOWN Parkinsons's Progression Marker Initiative
Sep 26, 2020·CNS Drugs·Ayushi Anna DineshAnthony C Vernon
Jun 25, 2020·The European Journal of Neuroscience·Nobuhito MuraiRudolf Jaenisch
Aug 7, 2019·Translational Psychiatry·George S Alexopoulos
Jun 22, 2019·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Junchao TongStephen J Kish
Mar 11, 2020·Proceedings of the National Academy of Sciences of the United States of America·Natalia LagoHugo Peluffo
Mar 13, 2020·Journal of Exercise Rehabilitation·Sung Ja RhieInsop Shim
Sep 26, 2020·Frontiers in Immunology·Linglin YangAnwen Shao
Feb 28, 2019·International Immunology·Tomoyuki FuruyashikiShiho Kitaoka
Mar 1, 2019·Frontiers in Cellular Neuroscience·Hisaomi SuzukiTakahiro A Kato
Jun 30, 2019·Molecular Psychiatry·Vijayasree V GiridharanTatiana Barichello
Jan 7, 2020·Journal of Neuroinflammation·Vijayasree V GiridharanTatiana Barichello
Jan 29, 2019·Frontiers in Psychiatry·Carsten CulmseeJudith Alferink
Oct 18, 2020·Science China. Life Sciences·Xiaoning JiaHailan Hu
Oct 30, 2020·Frontiers in Immunology·Alfonsina TirozziAlessandro Gialluisi
Jan 13, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Erik NutmaBenjamin B Tournier
Dec 15, 2020·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ogechi IgweSerdar M Dursun
Mar 10, 2020·The European Journal of Neuroscience·Romain TroubatVincent Camus
Feb 7, 2021·International Journal of Molecular Sciences·Kosma Sakrajda, Aleksandra Szczepankiewicz
Jan 31, 2021·Biological Psychiatry : Cognitive Neuroscience and Neuroimaging·Julia J SchubertFederico E Turkheimer
Feb 18, 2021·Journal of Neuroinflammation·Elnaz RoohiFarshad Hashemian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.